Successful Conclusion of the MEDICA Exhibition in Germany

 

From November 13th to 16th, 2023, the 55th edition of MEDICA, the International Trade Fair for Hospital and Medical Technology, took place as scheduled at the Düsseldorf Exhibition Center in Germany. Biotime showcased its platform-based testing solutions, including immunofluorescence, chemiluminescence, and colloidal gold, at this prestigious event.

 

 

During the exhibition, Biotime's multi-platform testing products made a stunning appearance, attracting numerous attendees to stop and visit.

 

 

 

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

 

√ 12 sample positions

√ HbA1c analysis in 2 minutes

√ The gold standard for the detection HbA1c

 

 

CLi-1600 semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood.

 

√ Lyophilized Powder: 2-30°C

√ Robust：16 Channels

√ Compact：312mm*382mm*345 mm

√ Homogeneous: No need washing

√ Accurate: CV ≦ 5%

√High Sensitivity: Nano-scaled particles

 

The FLI-100 Analyzer represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyzer was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyzer’ s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

 

√ Easy-to-use

√ Improved mobility

√ Efficient and cost-effective

√ Automatic self-check system

√ Connectivity

√ Extensive support

 

 

As a high-tech enterprise specializing in the research, development, production, and sales of in-vitro diagnostic reagents and instruments, Biotime adheres to a pragmatic and innovative approach, with a mission to apply science and technology to serve health. The company is committed to providing high-quality products and services to global users and contributing to the global medical and health industry with the strength of Biotime!